Bulk anonymised patient data (and I mean *bulk*) is of incredible value to medical and epidemiological research. Only if data spans the whole life of the patient can it identify for example early causes of Alzheimers.
Currently we are reliant on certain Scandinavian and Far-Eastern countries which have digitised their patient records and curated them to a high standard, the Americans have quantity but not quality, the British have not much of either. This needs to change and many countries are developing a suitable privacy-respecting national biomedical databank. The Swedish "National Genomics Platform" is a prototype that other countries are wishing, currently, that they had the common sense and basic IT skills to implement.